News reports today say that studies for two experimental drugs for Hepatitis C show positive results, and the Food and Drug Administration is likely to approve them in May.This is potentially good news for injecting drug users. In the UK, approximately 50% of injecting drug users are estimated to have Hepatitis C, which is a much more resilient virus then HIV, and therefore more easily transmitted by unhygienic injecting practices. Obviously, access to the treatments will depend on how much the drugs cost and whether they’ll be available within the NHS, but doctors are excited by the drugs’ results. Donald Jensen, a hepatologist at the University of Chicago School of Medicine is quoted as saying:

“This is the first time I can remember being so optimistic about this really difficult virus.”